clopidogrel

Generic: clopidogrel

Labeler: a-s medication solutions
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name clopidogrel
Generic Name clopidogrel
Labeler a-s medication solutions
Dosage Form TABLET
Routes
ORAL
Active Ingredients

clopidogrel bisulfate 75 mg/1

Manufacturer
A-S Medication Solutions

Identifiers & Regulatory

Product NDC 50090-6568
Product ID 50090-6568_660c9d3d-970a-4687-a3be-701644335d3b
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA202928
Listing Expiration 2026-12-31
Marketing Start 2022-08-09

Pharmacologic Class

Classes
cytochrome p450 2c8 inhibitors [moa] decreased platelet aggregation [pe] p2y12 platelet inhibitor [epc] p2y12 receptor antagonists [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 500906568
Hyphenated Format 50090-6568

Supplemental Identifiers

RxCUI
309362
UNII
08I79HTP27

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name clopidogrel (source: ndc)
Generic Name clopidogrel (source: ndc)
Application Number ANDA202928 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 75 mg/1
source: ndc
Packaging
  • 90 TABLET in 1 BOTTLE (50090-6568-0)
source: ndc

Packages (1)

Ingredients (1)

clopidogrel bisulfate (75 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "660c9d3d-970a-4687-a3be-701644335d3b", "openfda": {"unii": ["08I79HTP27"], "rxcui": ["309362"], "spl_set_id": ["3aef6fd4-7160-4678-9362-ca76174bfd0e"], "manufacturer_name": ["A-S Medication Solutions"]}, "finished": true, "packaging": [{"sample": false, "description": "90 TABLET in 1 BOTTLE (50090-6568-0)", "package_ndc": "50090-6568-0", "marketing_start_date": "20230728"}], "brand_name": "Clopidogrel", "product_id": "50090-6568_660c9d3d-970a-4687-a3be-701644335d3b", "dosage_form": "TABLET", "pharm_class": ["Cytochrome P450 2C8 Inhibitors [MoA]", "Decreased Platelet Aggregation [PE]", "P2Y12 Platelet Inhibitor [EPC]", "P2Y12 Receptor Antagonists [MoA]"], "product_ndc": "50090-6568", "generic_name": "Clopidogrel", "labeler_name": "A-S Medication Solutions", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Clopidogrel", "active_ingredients": [{"name": "CLOPIDOGREL BISULFATE", "strength": "75 mg/1"}], "application_number": "ANDA202928", "marketing_category": "ANDA", "marketing_start_date": "20220809", "listing_expiration_date": "20261231"}